Kairos Pharma logo

Kairos Pharma Share Price Today

(NASDAQ: KAPA)

Kairos Pharma share price is $1.14 & ₹99.31 as on 26 Feb 2025, 2.30 'hrs' IST

$1.14

-0.05

(-4.2%)

Market is closed - opens 8 PM, 26 Feb 2025

View live Kairos Pharma share price in Dollar and Rupees. Guide to invest in Kairos Pharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Kairos Pharma, along with analyst recommendations, forecasts, and comprehensive financials.

Kairos Pharma share price movements

  • Today's Low: $1.14
    Today's High: $1.25

    Day's Volatility :8.79%

  • 52 Weeks Low: $0.85
    52 Weeks High: $4.00

    52 Weeks Volatility :78.72%

Kairos Pharma (KAPA) Returns

PeriodKairos Pharma Ltd.Index (Russel 2000)
3 Months
-27.88%
0.0%
6 Months
-54.23%
0.0%
1 Year
-54.23%
0.0%
3 Years
-54.23%
-13.3%

Kairos Pharma (KAPA) Key Statistics

in dollars & INR

Previous Close
$1.19
Open
$1.16
Today's High
$1.2499
Today's Low
$1.14
Market Capitalization
$18.8M
Today's Volume
$154.6K
52 Week High
$4.0
52 Week Low
$0.851
Revenue TTM
$0.0
EBITDA
$-1.8M
Earnings Per Share (EPS)
$-0.21
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-375.74%

How to invest in Kairos Pharma Stock (KAPA) from India?

It is very easy for Indian residents to invest directly in Kairos Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Kairos Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Kairos Pharma or KAPA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Kairos Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Kairos Pharma shares which would translate to 0.764 fractional shares of Kairos Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Kairos Pharma, in just a few clicks!

Returns in Kairos Pharma (KAPA) for Indian investors in Rupees

The Kairos Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kairos Pharma investment value today

Current value as on today

₹48,937

Returns

₹51,063

(-51.06%)

Returns from Kairos Pharma Stock

₹56,154 (-56.15%)

Dollar Returns

₹5,091 (+5.09%)

Indian investors sentiment towards Kairos Pharma (KAPA)

-60%

Period: Jan 26, 2025 to Feb 25, 2025. Change in 30 Days versus previous period

Search interest for Kairos Pharma Stock from India on INDmoney has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Kairos Pharma

Analyst Forecast on Kairos Pharma Stock (KAPA)

What analysts predicted

Upside of 689.47%

Target:

$9.00

Current:

$1.14

Insights on Kairos Pharma Stock (Ticker Symbol: KAPA)

  • Price Movement

    In the last 7 days, KAPA stock has moved down by -10.5%

Kairos Pharma Technicals Summary

Sell

Neutral

Buy

Kairos Pharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Kairos Pharma (KAPA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Kairos Pharma Ltd. logo
-22.22%
-54.23%
-54.23%
-54.23%
-54.23%
Regeneron Pharmaceuticals, Inc. logo
4.17%
-40.53%
-28.2%
15.35%
60.44%
Beone Medicines Ltd logo
14.76%
30.45%
43.85%
22.79%
63.24%
Vertex Pharmaceuticals Incorporated logo
8.51%
-1.65%
11.77%
109.39%
114.99%
Alnylam Pharmaceuticals, Inc. logo
-10.04%
-11.31%
56.57%
57.71%
111.58%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Kairos Pharma Ltd. logo
NA
NA
NA
-0.1
-3.76
-0.42
NA
0.26
Regeneron Pharmaceuticals, Inc. logo
18.28
18.28
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
-5.69
-0.23
-0.1
NA
226.72
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.11
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.59
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Kairos Pharma Ltd. logo
NA
$18.8M
-54.23%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$76.6B
60.44%
18.28
31.07%
Beone Medicines Ltd logo
NA
$29.9B
63.24%
NA
-25.5%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.3B
114.99%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$32.4B
111.58%
NA
-12.37%

About Kairos Pharma

Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops therapeutics for cancer patients. Its therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The company develops KROS 101 and 102, which are small molecules that are agonist and antagonist for the glucocorticoid induced TNF-like receptor ligand; KROS 201, an autologous T cell therapy targeting cancer stem cells of glioblastoma; KROS 301, a small molecule that targets the NF-"ß pathway, a cancer growth and immune suppressive molecule in triple negative breast cancer; and KROS 401, a cyclic peptide, which inhibits the IL-4 and IL-13 receptors. It also develops ENV 105, an antibody that targets CD105/Endoglin, which expressed in tumor cells and surrounding cells; and ENV 205, an antibody that targets mitochondrial DNA. Kairos Pharma, Ltd. was formerly known as NanoGB13, Inc. and changed its name to Kairos Pharma, Ltd. in July 2016. The company was incorporated in 2013 and is based in Los Angeles, California.
Organization
Kairos Pharma
Employees
0
CEO
Dr. John S. Yu M.D., Ph.D.
Industry
Miscellaneous

Management People of Kairos Pharma

NameTitle
Dr. John S. Yu M.D., Ph.D.
CEO, Chairman & Secretary
Mr. Douglas W. Samuelson CPA
Chief Financial Officer
Dr. Neil A. Bhowmick Ph.D.
Chief Scientific Officer
Dr. Ramachandran Murali Ph.D.
Vice President of Research & Development

Important FAQs about investing in KAPA Stock from India :

What is Kairos Pharma share price today?

Kairos Pharma share price today stands at $1.14, Open: $1.16 ; Previous Close: $1.19 ; High: $1.25 ; Low: $1.14 ; 52 Week High: $4.00 ; 52 Week Low: $0.85.

The stock opens at $1.16, after a previous close of $1.19. The stock reached a daily high of $1.25 and a low of $1.14, with a 52-week high of $4.00 and a 52-week low of $0.85.

Can Indians buy Kairos Pharma shares?

Yes, Indians can invest in the Kairos Pharma (KAPA) from India.

With INDmoney, you can buy Kairos Pharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Kairos Pharma at zero transaction cost.

How can I buy Kairos Pharma shares from India?

It is very easy to buy Kairos Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Kairos Pharma (KAPA) be purchased?

Yes, you can buy fractional shares of Kairos Pharma with INDmoney app.

What are the documents required to start investing in Kairos Pharma stocks?

To start investing in Kairos Pharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Kairos Pharma Stock (KAPA)?

Today’s highest price of Kairos Pharma (KAPA) is $1.25.

Today’s lowest price of Kairos Pharma (KAPA) is $1.14.

What is today's market capitalisation of Kairos Pharma?

Today's market capitalisation of Kairos Pharma KAPA is 18.8M

What is the 52 Week High and Low Range of Kairos Pharma Stock (KAPA)?

  • 52 Week High

    $4.00

  • 52 Week Low

    $0.85

What are the historical returns of Kairos Pharma (KAPA)?

  • 1 Month Returns

    -22.22%

  • 3 Months Returns

    -54.23%

  • 1 Year Returns

    -54.23%

  • 5 Years Returns

    -54.23%

Who is the Chief Executive Officer (CEO) of Kairos Pharma ?

Dr. John S. Yu M.D., Ph.D. is the current Chief Executive Officer (CEO) of Kairos Pharma.